Business
Issue of Shares to EBT and Total Voting Rights
Issue of Shares to EBT and Total Voting Rights.
About this update from Lendinvest Plc
[{"type":"text","content":"\n\n20 August 2024\nLendInvest plc\n(\"LendInvest\" or the \"Company\")\nIssue of Shares to the Employee Benefit Trust\nand\nTotal Voting Rights\nLendInvest plc (AIM: LINV) today announces the proposed issue and allotment of 1,750,000 new ordinary shares in the capital of the Company of £0.0005 each (the \"New Shares\") intended to be subscribed for at par value by Equiniti Trust (Jersey) Limited (the \"Trustee\"), as trustee of the LendInvest Employee Benefit Trust (the \"EBT\"). The EBT is subscribing for the New Shares to satisfy the grant of share awards to employees and the expected exercise of vested share options held by employees under the Company's share plans.\nThe subscription costs for the New Shares will be funded by way of a loan from the Company to the EBT. The New Shares will rank pari passu in all respects with the Company's existing Ordinary Shares.\nApplication has been made to London Stock Exchange plc for admission of the New Shares to trading on AIM (\"Admission\"). It is expected that Admission will become effective on 21 August 2024.\nFollowing Admission, the total number of Ordinary Shares held by the EBT will be 2,467,937 representing approximately 1.7% of the Company's total voting rights.\nFollowing Admission, the total number of shares in issue in the Company will be 142,782,025. The Company does not hold any shares in treasury and all shares have equal voting rights. Therefore, the total number of voting rights in the Company, following Admission, will be 142,782,025. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, LendInvest under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.\nFor further information, please contact:\nLendInvest via Teneo +44 (0)20 7353 4200\nRod Lockhart, Chief Executiv...